Abstract
There was no significant difference in the pharmacokinetic parameters of tolbutamide (500 mg) determined before and after 14 days treatment with tenoxicam (20 mg/day) in 7 healthy volunteers (6 male, 1 female). In addition, co-administration of tenoxicam did not alter blood glucose concentrations.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Analysis of Variance
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Blood Glucose / metabolism*
-
Chromatography, High Pressure Liquid
-
Computer Simulation
-
Drug Interactions
-
Female
-
Humans
-
Male
-
Middle Aged
-
Piroxicam / administration & dosage
-
Piroxicam / analogs & derivatives*
-
Piroxicam / pharmacology
-
Tolbutamide / administration & dosage
-
Tolbutamide / blood
-
Tolbutamide / pharmacokinetics*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Blood Glucose
-
Piroxicam
-
Tolbutamide
-
tenoxicam